Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 68462-720

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 68462-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister

Blister card for drospirenone and ethinyl estradiol tablets USP, 3 mg/0.02 mg, arranged in a 4-week dosing schedule labeled by day of the week from Sunday to Saturday, with arrows indicating the pill-taking sequence. The chart includes weekly rows labeled Week 1 to Week 4 to guide daily tablet administration.*

FDA Label Image

Carton

Packaging label for Drospirenone and Ethinyl Estradiol Tablets, USP 3 mg/0.02 mg kit by Glenmark Pharmaceuticals Inc., USA. The carton states it contains 3 blisters, each with 28 tablets. The label includes dosage instructions, storage information, and a barcode, with branding and product details on all sides of the kit packaging.*

FDA Label Image

Chart

A vertical chart depicting the effectiveness of various birth control methods. The chart shows fewer pregnancies per 100 women per year at the top, with methods like implants, injections, intrauterine devices, and sterilization, including birth control pills, skin patch, and vaginal ring with hormones. Mid-level effectiveness lists condoms and diaphragm, lower effectiveness methods include no sex during fertile days, spermicide, and withdrawal, and highest pregnancy rates occur with no birth control.*

FDA Label Image

Drospirenone

Chemical structure of drospirenone, one of the active ingredients in the drospirenone and ethinyl estradiol combination drug.*

FDA Label Image

Eestructure

Chemical structure of drospirenone and ethinyl estradiol active ingredients, shown as a molecular diagram illustrating their chemical bonds and rings.*

FDA Label Image

Figure1

A forest plot comparing hazard ratios, rate ratios, and odds ratios from various studies including Ingenix, EURAS, LASS, FDA-funded study, Danish, Danish re-analysis, MEGA, German case-control, PharMetrics, and GPRD. The studies are grouped into prospective cohort, retrospective cohort, case-control, and non-fatal idiopathic cases only, with each study's ratio represented as a diamond or square along a logarithmic axis ranging from 0.1 to 10.*

FDA Label Image

Figure2

A bar chart comparing the number of women with blood clots per 10,000 women years (WY) among different groups: Non-Pregnant Non-COC users, COC users, Pregnant women, and Postpartum women (12 weeks only). The chart shows ranges of blood clot rates for each group from lowest in Non-Pregnant Non-COC users to highest in Postpartum women.*

FDA Label Image

Figure3

A forest plot showing effect estimates from various studies comparing contraceptive use status with a health outcome. Studies include NICHD Women's Care Study, French E3N cohort, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The horizontal axis represents effect estimates ranging from approximately -1.5 to 2.0, with confidence intervals shown as lines through dots representing the point estimates for each study.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo1

FDA Label Image

Serious Blood Clot

A bar chart showing the number of women with a blood clot per 10,000 women years across four groups: Non-Pregnant Non-COC users (1 to 5), COC users (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) (40 to 65). The chart compares clot rates among these groups with pregnancy duration based on reference study data.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.